DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Kantrowitz JT, Woods SW, Petkova E. et al.
D-serine for the treatment of negative symptoms in Individuals at clinical high risk of schizophrenia: A pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial.
Lancet Psychiatry 2015;
2: 403-412
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.